Programme for Pharma IQ's 10th Annual ELNs and Advanced Laboratory Solutions Forum

1. Presents the 10th Annual Europe’s ONLY ELNs event!
Register and pay before 27th
May 2011 and save up to €600!
Two Day Conference:
27th-28th September 2011
Pre-Conference Focus Day & Workshops:
26th September 2011
Venue: Hilton, Barcelona, Spain
Hear from over 30 experts including:
Tina Spendler
Project Manager, Novozymes
Increase productivity, innovation and Michael Elliott
CEO, Atrium Research & Consulting
collaboration by implementing the best Markus Duerring
IT Account Manager, Novartis Institutes
ELNs for your lab for BioMedical Research
Jim King
Our expert speaker faculty will show you how to: Director, R&D Business Technology,
• Promote interoperability between your ELNs and your facility’s other systems Pfizer Diversified Businesses
and instruments with Pfizer and Swedish Orphan Biovitrum Manli Zheng
• Select the right ELNs for your lab by determining which functionalities are Senior Group Leader, Scientific Informatics and
necessary, which are desirable and which products fulfil your specific needs Automation, Abbott
with the help of companies like Lonza and LEO Pharma
John Trigg
• Explore innovative technologies like the brand-new SharePoint-based Director, phaseFour Informatics
system used by Novozymes and assess their applicability to your lab
Seth Pinsky
• Secure your intellectual property by assessing risks, developing safeguards Director, Scientific Informatics and
and complying with regulations under the guidance of Perkins Coie Automation, Abbott
• Cultivate the global ELN solutions necessary when outsourcing to CROs and
CMOs, testing in developing countries and integrating post-mergers and Julie Spry
acquisitions - learn from Abbott’s experience Principal Scientist, Pfizer
Colin Sandercock
Partner, Perkins Coie LLP
Don’t Miss the In-Depth, Interactive Pre-Conference Focus Day and Workshops!
Ian Menzies
Focus Day Interoperability - It’s Hard to Pronounce and Even Harder to Achieve: Senior Information Manager, AstraZeneca
Expediting Your Lab’s Workflow Through Informatics Integration Full speaker panel inside…
Workshop A Increasing the Semantic Capabilities of Your ELN to Capture More
Complete Data with Jeremy Frey
Workshop B Navigating Regulations and Ensuring the Legality of Your IP From the This conference has been
R&D Stage Forward with Colin Sandercock valuable, giving me up-to-date
information on ELNs & ways to
www.elnforum.com improve our system & practices.
General Mills
SPONSORS & EXHIBITORS
CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com

2. YOuR 2011 EXPERT SPEakER PaNEl
Seth Pinsky Ulrik Nicolai de Lichtenberg
Director, Scientific Informatics and Automation Head of Research Informatics & Data Management
Abbott LEO Pharma
Manli Zheng James Sullivan
Senior Group Leader, Scientific Informatics Business Excellence Manager
and Automation Lonza Custom Manufacturing Mammalian
Abbott Division
Dominique Vlieghe Markus Duerring
Senior Bioinformatician IT Account Manager
Ablynx NV Novartis Institutes for BioMedical Research
Valentina Cappello Raquel Dias Miranda
Discovery Data Management Unit Global Application Service Manager
Almirall Novartis Institutes for BioMedical Research
Cat Andersen Debra Kassabian
Lead Scientific Data Analyst Global Lead Chemistry Information Systems
Array BioPharma Novartis Institutes for BioMedical Research
Jim Rizzi Tina Spendler
Computational Technology Director Project Manager
Array BioPharma Novozymes
Ian Cooper John Trigg
Director
Strategy & Portfolio Director phaseFour Informatics
AstraZeneca
Julie Spry
Ian Menzies Principal Scientist
Senior Information Manager Pfizer
AstraZeneca
Jim King, Director
Michael Elliott R&D Business Technology
CEO Pfizer Diversified Businesses
Atrium Research & Consulting
Colin Sandercock
Jens Koehler Partner
Project Manager Perkins Coie LLP
BASF SE
Bernhard Schirm
Pedro Castanheira Managing Director
Researcher, Molecular Biology Unit Quattro Research
Biocant
Torsten Sejlitz
Lieselot Bontinck Senior Scientist in Informatics and Automation
Senior Research Associate Pharmacology Swedish Orphan Biovitrum
Ablynx NV
Julia Hadley
Morten Meldgaard Senior Business Analyst
Project Manager Syngenta
Chr. Hansen A/S
James Peace
Paul Denny-Gouldson Senior Research Chemist
Vice President of Translational Medicine Syngenta
IDBS
Jeremy Frey
Danny Verbinnen Professor of Physical Chemistry
IT Manager University of Southampton
Janssen R&D, Johnson & Johnson
CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com

3. PRE CONfERENCE fOCuS DaY & WORkSHOPS: 26TH SEPTEmBER 2011
fOCuS DaY: INTEROPERaBIlITY—IT’S HaRD TO PRONOuNCE aND HaRDER TO aCHIEVE
Expediting Your lab’s Workflow Through Informatics Integration
9.30 Pharma IQ Welcome and Chairperson’s Opening Remarks 11.40 Managing Your Newfound Wealth of Data
John Trigg, Director, phaseFour Informatics • Deciding what you need your informatics systems to do: collect,
store, transfer, sort, analyse and retrieve data
9.40 The Answer’s an ELN: What Was the Question? • Determining which tools offer the greatest usability
Facilitating Collaboration Between Your LIMS and Your ELNs • Looking at promising developments (tools, functionalities and
• Determining which data belongs in your LIMS and which belongs software) on the horizon and anticipating potential compatibility
in your ELN issues
• Avoiding redundancies in functionalities or data storage Torsten Sejlitz, Senior Scientist in Informatics and Automation,
• Creating collaborative data sharing between your informatics systems Swedish Orphan Biovitrum
John Trigg, Director, phaseFour Informatics
12.20 Group Therapy Lunch
10.20 Juggling the Informatics Needs of Biology and Chemistry The Triumphs and Tribulations of Integration
Laboratories This session is designed to help increase dialogue and knowledge
• Identifying the disparate needs of biology and chemistry labs transfer between leading industry experts, solution providers and
• Weighing the pros and cons of separate bio and chem ELNs end users. To facilitate this lunchtime learning, the session leader
versus one ELN for both purposes will begin with a few suggestions of major challenges related to
• Creating an ELN that satisfies the needs of both bio and chem labs interoperability and open the discussion to the audience. The “group
or developing the tools necessary for data transfer therapy” learning format opens the lines of communication and is
Jim King, Director, R&D Business Technology, Pfizer Diversified designed for speakers, delegates and service providers alike.
Businesses
Please come prepared to discuss your greatest challenges and
11.00 Integrating Via the Web to Create a More Seamless ELN share your successes in the ongoing battle for compatibility among
• Creating an innovative new web service layer with a preexisting informatics systems.
ELN at Novartis Facilitator:
• Streamlining functions such as registration, signing and Seth Pinsky, Director, Scientific Informatics and Automation, Abbott
witnessing, analytics requests, assay submissions and more
• Expediting data input and transfer without increasing dependency 13.20 Chairperson’s Closing Remarks and End of Focus Day
on integration John Trigg, Director, phaseFour Informatics
Debra Kassabian, Global Lead Chemistry Information Systems, NIBR
Raquel Dias Miranda, Global Application Service Manager, NIBR
PRE-CONFERENCE WORKSHOPS: 26TH SEPTEMBER 2011
15.45–16.45 WORkSHOP a
Increasing the Semantic Capabilities of Your ElN to Capture more Complete Data
There is a growing movement within life-science laboratories to attach a more comprehensive level of semantic information to the data captured within
ELNs. This workshop will delve into issues like:
• Defining the term semantics as it applies in the laboratory and explaining the importance of semantically rich data capture
• Identifying which semantic data your ELN can and should collect and store
• Implementing a strategy for collecting semantic annotations at source, using semantic web technology and developing knowledge grids
• Utilising semantics to enhance searachability, collaboration and automated processes such as data mining
Jeremy Frey, Professor of Physical Chemistry, University of Southampton
17.00–20.00 WORkSHOP B
Navigating Regulations and Ensuring the legality of Your IP from the R&D Stage forward
Ensuring the safety of your intellectual property is of paramount importance; you need to keep it confidential, compliant with regulations and legally
protected. The workshop will cover:
• Assessing the current regulations in place in both the US and the EU
• Discussing risk-based ELN validation (is it necessary to validate in early research stages?) and identifying the appropriate time to apply
authentication methods such as time-stamping and digital signatures
• Developing a standard protocol to ensure record integrity and legality in your lab or across your entire company
• Creating a long-term data archive that is secure and legally compliant, yet accessible to laboratory personnel
Colin Sandercock, Partner, Perkins Coie LLP
CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com

4. CONFERENCE DAY ONE: TUESDAY 27TH SEPTEMBER 2011
08.00 Registration and Coffee 11.00 Networking Coffee Break
08.50 Pharma IQ Welcome and Chairperson’s Opening Address, CONFIGURING YOUR INFORMATICS FOR IMPROVED WORKFLOW
Michael Elliott, CEO, Atrium Research & Consulting Defining the terms, identifying key challenges and deciding what you need in an ELN
DISCUSSING THE STATE OF THE INDUSTRY 11.30 Delineating the Grey Area Between ELNs and LIMS
Where are ELNs now, where are they headed and is your lab on track? • Understanding the common definitions of LIMS and ELNs
09.00 Moving Toward an Ideal Future State • Identifying where system functionalities overlap and differ
• Examining the ways in which ELNs have improved data management • Following the development of each system and predicting their
and operational efficacy and theorising future developments trajectories - will the paths of ELNs and LIMS converge, diverge or
• Understanding the data process issues laboratories face and continue to run parallel?
identifying how to resolve them using technology such as ELN Markus Duerring, IT Account Manager, NIBR
as an enabler 12.10 Creating an Informatics Ecosystem: Promoting a Integrated Lab Programme
• Investigating new technologies, their practicality and utility • How Pfizer tackled the challenges of integrating multiple solutions
Michael Elliott, CEO, Atrium Research & Consulting (LIMS, ELNs, SDMS, CDS) across two business divisions
09.40 Panel Discussion: 10 Years of ELNs - A Look Back (and a Look Forward) • Changing the cultural view of informatics as individual components and
• Tracing the progress of ELNs over the last decade as they’ve moved promoting the perception of an intra-organisation informatics ecosystem
from novelty to vital laboratory informatics system • Streamlining data input and storage by creating data standards across
• Recognising key developments in the field, identifying problem laboratories, departments, your entire company and even external collaborators
areas that still exist and contemplating possible solutions Jim King, Director, R&D Business Technology, Pfizer Diversified Businesses
• Forecasting future trends and developments - where do ELNs go 12.50 Using an ELN as a Source for Data Warehousing
from here? • Moving from the more traditionally structured systems that feed
Panellists: John Trigg, Director, phaseFour Informatics data warehouses and incorporating your ELN as a source
Jim Rizzi, Computational Technology Director, Array BioPharma • Transferring your data from your ELN and into a warehouse
Danny Verbinnen, IT Manager, Janssen R&D, Johnson & Johnson • Efficiently utilising your data in an integrated warehouse
Debra Kassabian, Global Lead Chemistry Information Systems, NIBR Bernhard Schirm, Managing Director, Quattro Research
10.20 Where ELNS are Heading: Wide, Deep and High 13.05 Networking Lunch Break
• Wide – the ever expanding markets for ELNS
• Deep – blurring the edges between LIMS and ELN
• High – taking ELNS into the cloud
Paul Denny-Gouldson, Vice President of Translational Medicine, IDBS
STREAM A STREAM B
TACkLING PRE- AND EARLY ELN IMPLEMENTATION ISSUES ADDRESSING THE CHALLENGES FACED MID-ELN IMPLEMENTATION TO POST-ROLLOUT
14.20 Panel Discussion: Demonstrating the ROI for ELN and Effectively 14.20 Case Study: Developing and Implementing a Global QC Systems
Communicating This to Senior Management Strategy to Drive Efficient Laboratory Operation
• Building the business case for implementation CASE • Creating a four-tier QC system strategy (SAP-LIMS-ELN-CDS) that
• Setting benchmarks and measuring KPIs STUDY drives efficiency and compliance in QC laboratories
• Fostering operational excellence through the use of your ELNs • Driving global implementation through process standardisation and
Panellists: programme governance
Valentina Cappello, Discovery Data Management Unit, Almirall • Examining benefits realised from the approach adopted by AstraZeneca
Pedro Castanheira, Researcher, Molecular Biology Unit, Biocant and areas for future development and exploitation
James Sullivan, Business Excellence Manager, Lonza Custom Ian Cooper, Strategy & Portfolio Director, AstraZeneca
Manufacturing, Mammalian Division
15.00 Effectively Collaborating With External Partners (CROs, CMOs and
15.00 Case Study: Ensuring End-User Support for Your ELN Project From Outsourced Testing Facilities)
Selection Through Upgrades • Balancing between legal contracts and trust thereby ensuring the
CASE • Identifying champions and skeptics within your organisation,
security of your IP
STUDY understanding their concerns and (hopefully) converting the naysayers • Planning pragmatically for quick deployment and sustainability while
• Drafting a comprehensible, transparent change management strategy capturing partner work details and data in a timely fashion
• Incorporating end-user suggestions and feedback from project • Understanding CRO organisations and the local culture
inception onward Manli Zheng, Senior Group Leader, Scientific Informatics and
James Peace, Senior Research Chemist, Syngenta Automation, Abbott
Julia Hadley, Senior Business Analyst, Syngenta
15.40 Networking Coffee Break 15.40 Networking Coffee Break
16.10 Panel Discussion: Selecting the Best ELN for Your Lab 16.10 Case Study: Implementing a Hybrid (GLP/Non-GLP) ELN at Novartis
• Determining your lab’s informatics needs and desires Considering • Ascertaining which is more beneficial: building two separate
the available informatics options - do you need both a LIMS and an CASE instances of your ELN or one that can multitask
ELN? Only one? Which? STUDY • Ensuring your system meets the needs of different audiences: it
• Ensuring your ELN is both backwards-compatible and as future- must comply with health authority regulations for GLP operations
proof as possible and it must provide the required flexibility for non-GLP operations
Panellists: • Determining the best validation approach to build a system that
Ulrik Nicolai de Lichtenberg, Head of Research Informatics & Data stores validated and unvalidated data
Management, LEO Pharma Markus Duerring, IT Account Manager, NIBR
James Sullivan, Business Excellence Manager, Lonza Custom 16.50 Aligning Your ELN to Your Business - How Far Do You Go?
Manufacturing, Mammalian Division COTS, Code, Configuration and Customisation
16.50 Validating Your ELNs for GxP Use • Discussing the differences in generic and domain-specific ELNs
• Defining validation and understanding its utility and applicability to ELNs • Understanding the consequences of storing data in structured vs.
• Guidelines for implementing a ground-up validation program in your facility unstructured formats and developing appropriate templates
• Ensuring user comprehension and compliance with GxP methods • Deciding who owns your ELN - how much vendor support
Ian Menzies, Senior Information Manager, AstraZeneca do you need and want and how much responsibility does your
organisation want to shoulder?
Dominique Vlieghe, Senior Bioinformatician, Ablynx NV
17.30 Q&A: Ask an End User
These are the folks who don’t make the ELNs decisions, but do reap the rewards (or suffer the consequences). Learn how a company’s ELN adoption choices
affect system users – what works well, what needs aren’t being met, what discoveries have been made during the adoption process. Get the user input you need
before implementing a new ELN or making changes to your existing system!
Lieselot Bontinck, Senior Research Associate Pharmacology, Ablynx NV
18.00 Chairperson’s Closing Remarks and Close of Day One Michael Elliott, CEO, Atrium Research & Consulting

5. CONFERENCE DAY TWO: WEDNESDAY 28TH SEPTEMBER 2011
08.30 Registration and Coffee 12.10 Networking Lunch Break
08.50 Chairperson’s Opening Address 13.40 Launching an ELN to Humans
Michael Elliott, CEO, Atrium Research & Consulting It’s Not Just About the Technology
• Making sure that the user - the ultimate consumer for the ELN -
ASSESSING NOVEL TECHNOLOGIES AND THEIR APPLICABILITY TO YOUR LAB doesn’t get lost in the implementation process
What do they do, who’s using them and which are right for you? • Determining how scientists and other lab personnel will use the ELN
• Choosing an ELN that suits the needs of not just your lab, but the
09.00 Case Study: Building an In-House ELN Using a Microsoft SharePoint people who work there
Platform James Sullivan, Business Excellence Manager, Lonza Custom
• Outlining the rationale behind Novozymes’ decision to create an Manufacturing, Mammalian Division
in-house ELN based on SharePoint instead of relying on an off-
the-shelf product 14.20 ELN Clinic: Attacking Challenges Head-On
• Incorporating significant user group feedback in order to develop Join one of the following roundtables to collaboratively attack a
a system that fits the needs of users hypothetical challenge, create a plan of action and solve the
• Analysing the benefits (such as enhanced collaboration potential) problem. Scenarios will include:
and drawbacks (such as creating additional code) of using • Informatics decisions in the wake of a merger or acquisition
SharePoint Facilitator: Julie Spry, Principal Scientist, Pfizer
Tina Spendler, Project Manager, Novozymes • Working with an outdated ELN
Facilitator: Cat Andersen, Lead Scientific Data Analyst, Array BioPharma
EFFECTIVELY UTILISING YOUR ELNS IN NONTRADITIONAL CONTEXTS AND • ELN data warehousing and data mining for discovery
TRICKY SITUATIONS Facilitator: Manli Zheng, Senior Group Leader, Scientific Informatics
Ensuring your ELN is a help, not a hindrance and Automation, Abbott
Choose one of three tables to join!
9.40 Case Study: Planning a Successful ELN Implementation at a Food
Ingredient Company 15.00 Networking Coffee Break
CASE • Ascertaining what needs an ELN must address within a global
STUDY
food ingredient company and what criteria are paramount within 15.30 Case Study: Implementing an ELN in a Biotherapeutics Pharm Sci
the selection process Organisation
• Creating and adhering to an aggressive implementation timeline CASE • Testing available ELN solutions to determine suitability for use
(while incorporating end user feedback in the process) STUDY in a large-molecules lab
• Utilising an ELN as a vehicle for improved knowledge sharing and • Harmonising the needs of the lab with the needs of other
moving toward open innovation departments within the company
Morten Meldgaard, Project Manager, Chr. Hansen A/S • Encouraging company-wide collaboration and enhancing system
and procedural compatibilities
10.20 Networking Coffee Break Julie Spry, Principal Scientist, Pfizer
10.50 Designing Your ELNs for Reliability and Performance 16.10 Leveraging an ELN to Improve Work Processes in the Lab at BASF
• Ensuring the real-time availability of your ELN across all • Improving laboratory workflows
• Strengthening information exchange and knowledge sharing
geographies (with a minimum of downtime) • Developing methods for successful implementation of an ELN
• Achieving an acceptable level of fault tolerance and a reasonable Jens Koehler, Project Manager, BASF SE
level of performance
• Facilitating communication and collaboration across multiple sites 16.50 Chairperson’s Closing Remarks and Close of Conference
(branches and contractors alike) Michael Elliott, CEO, Atrium Research & Consulting
Seth Pinsky, Director, Scientific Informatics and Automation, Abbott
11.30 Speed Networking, ELNs Edition “ELN is a new area for me.
Like Speed Dating, But Without the Pressure to Commit
You’ve seen each other across the room…now meet face-to-face.
Conference very informative!“
Bring plenty of business cards to exchange in a series of 2-3 minute Nofima Mat AS
one-on-one meetings with your fellow speakers, attendees and
vendors. Your mission - learn one of the following things about each “A good opportunity to get best
person you meet:
• What is your biggest ELN challenge?
practices in ELN integration.“
• What has been your greatest ELN-related success? L’Oreal
• What do you hope to get out of the conference?
media Partners

6. SPONSORS AND EXHIBITORS
Session Sponsors
IDBS is a leading provider of advanced software solutions. IDBS’ applications are integrated data management, analysis and decision-making
products used in the drug discovery industry to acquire, manage and use chemical and biological data. IDBS’customers includes the world’s leading
pharmaceutical, biotechnological and other discovery research based companies.
Website: www.idbs.com
Gold Exhibitor
Quattro research addresses the needs of life science and chemical industry by providing state-of-the-art solutions to manage all scientific data
produced in research projects. Our applications help scientists to optimise the value of their research data, e.g. the electronic lab notebook quattro/LJ
or the compound management solution quattro/CM, quattro research offers software and consulting services to build and integrate heterogeneous
data sources and applications, such as compound registration, HTS, LIMS or SAP, into efficient and user friendly data management platforms.
Website: www.quattro-research.com
featured Exhibitors
Accelrys, a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific
innovation to differentiate themselves. Accelrys’ Enterprise R&D Architecture, built on the industry leading Pipeline PilotTM platform, enables
customers to access, organize, analyze and share scientific data in unprecedented ways, ultimately enhancing innovation, improving productivity
and compliance, reducing costs and speeding time from lab to market
Website: www.accelrys.com
Agilent Technologies is a leading supplier of life science research systems that enable scientists to understand complex biological processes,
determine disease mechanisms and speed drug discovery. Engineered for sensitivity, reproducibility and workflow productivity, Agilent’s life
science solutions include instrumentation, microfluidics, software, microarrays, consumables and services for genomics, proteomics and
metabolomics applications.
Website: www.agilent.com
CambridgeSoft is a leading provider of software and services for discovery, analysis and collaboration to life sciences and chemical
industries, academia and government. Its integrated product suite improves the productivity of researchers in the discovery, development
and commercialization of chemical and biological compounds. Products include Cloud, Enterprise, Workgroup and Desktop versions of Chem
& Bio Office, including Chem & Bio Draw and E-Notebook, providing knowledge management, chemical and biological informatics and
scientific database solutions.
Website: www.cambridgesoft.com
Contur Software is a focused software company delivering innovative products and services to R&D organizations worldwide. Its proven
Electronic Lab Notebook system enables customers to have instant access to their experimental data and results at any time from any location.
The system is particularly known for its intuitive graphical user interface and flexible architecture enabling rapid deployments and cost effective
operation. iLabber is offered both as an on-premise server based install – iLabber Server – and via a SaaS (Software-as-a-service) model –
iLabber Cloud. The iLabber system is used by thousands of users worldwide in the Biotech, Chemical, Food & Beverage and Academic sectors.
Website: www.contur.com
LabWare is the world’s leading LIMS product used in more than 70 countries worldwide. LabWare LIMS includes an extensive library
of “out-of-the-box” features, functions and modules delivering real business advantage for LabWare’s customers. LabWare can now provide
a seamlessly integrated experiment and workflow driven ELN designed to give the laboratory scientist the ultimate platform to electronically
document their experiments including relevant scientific content and observations, results and attachments such as spectra, chromatograms
and, if appropriate, chemical structures. LabWare has invested in providing a truly global support network backed by some of the most
experienced LIMS professionals in the world.
Website: www.labware.com
Sponsorship & Exhibition
maximise Your Involvement: Sponsorship and Exhibition Opportunities
Pharma IQ’s ElNs & advanced laboratory Solutions is Europe’s long-running and only event dedicated to ELNs and their users. This year’s conference
features two streams catering to individuals at different stages in their ELN implementations: one targeted to organisations in the pre-and early
implementation phases and another dedicated to companies in the mid-implementation to post-rollout stages.
The conference is attended by key decision-makers - end users who champion ELN projects, IT/IS personnel who facilitate implementation, senior officials
who approve the purchase of systems - bringing together buyers and suppliers together in one place.
Focused and high-level, the event will be an excellent platform to initiate new business relationships. With tailored networking, sponsors can achieve the
face-to-face contact that overcrowded trade shows cannot deliver.
Exhibiting and Sponsorship options are extensive and packages can be tailor-made to suit your company’s needs. Packages include complimentary entry
passes, targeted marketing to industry officials and executives and bespoke networking opportunities.
Other features of sponsorship include:
• Prominent exhibition space in the main conference networking area
• Participation in comprehensive pre-event marketing campaigns
• Tailored marketing strategies to suit your organisation’s size, capabilities and individual requirements
For more information and to discuss the right opportunity, contact Gal Cohen on +44 (0)207 368 9300 or sponsorship@iqpc.co.uk
about Pharma IQ
Become a member of Pharma IQ and receive complimentary access to resources that will keep you at the forefront of industry change. You will
receive access to our growing library of multimedia presentations from industry leaders, an email newsletter updating you on new content that
has been added, free aggregated news feed from over 1000 global news sources tracking your industry and special member only discounts on
events. Become a member here: www.pharmaceuticaliq.com
CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com

7. THE LEADING GLOBAL FORUM FOR ELN AND DATA MANAGEMENT PROFESSIONALS
after a very successful 2010 conference, Pharma IQ’s ElNs event has returned and
is celebrating its 10th anniversary. 2011 promises new case studies, two streams of Delegate Profile for Pharma IQ’s ElN forum
presentations targeted at individuals at all stages of implementation and a focus day
designed to tackle one of the most omnipresent issues in the industry - interoperability.
The conference has achieved the unrivalled status of Europe’s leading ElN forum
through consistently delivering critical, timely and practical case studies, workshops
and discussion groups, as well as providing unparalleled networking opportunities for
attendees and solution providers alike. Join us to celebrate 10 successful years!
Over the past 9 years Pharma IQ’s ElNs forum has welcomed attendees from
these companies:
4SC AG iNovacia
Abbott Laboratories Institut de Recherches SERVIER
Ablynx NV Ipsen Pharma SA
Accelrys Ltd Janssen Pharmaceutica Country Total %
ACRAF SpA Johnson & Johnson
Actelion Pharmaceuticals Ltd. KineMatik Australia 1.60
Agilent Techniologies Laboratory Data Solutions
ALK-Abelló LabWare
Austria 1.60
Allergan Inc. LEK Pharmaceutical d.d. Belgium 11.20
Almirall Prodesfarma Research Centre LEO Pharma AS
Amphora Research Systems LiPlasome Pharma A/S Denmark 12.80
Amsterdam Molecular Therapeutics (AMT) bv Lonza Group Ltd. France 8.00
Array BioPharma Inc L’Oreal
Astellas L’Universite Libré de Bruxelles Germany 9.60
AstraZeneca Mars
Asubio Pharma MedImmune Ltd.
Ireland 0.80
Atrium Research Merck Italy 0.80
BASF Merz Pharma
Basilea Pharmaceutica AG Metler Toledo Japan 2.40
Baxter Healthcare Corporation Metron Inc. Norway 0.80
Bayer Schering Pharma AG Millennium Pharmaceuticals Inc.
Biogen Idec Mundi Pharma Research Spain 4.00
Biovitrum AB Nestlé Research Centre Sweden 3.20
Bistows Nofima Mat AS
Boehringer Ingelheim Pharma GmbH & Co. KG Novartis International AG Switzerland 8.80
Bristol - Myers Squibb Novo Nordisk AS
Cambridge University Novozymes AS The Netherlands 6.40
CambridgeSoft NV Organon United Kingdom 17.60
Carmeda AB Omnichem
Centre for Ecology and Hydrology Oracle United States 10.40
ChemAxon Ltd Pfizer Ltd.
Chiesi Farmaceutici SPA PhaseFour Informatics
Chr Hansen AS Philip Morris International
Cirrus Pharmaceuticals PRA International
Concurrent Technologies Corporation Proskauer Rose LLP
Contur Roche Diagnostics GmbH
CSIRO Roche Palo Alto
CSL Bioplasma Roche Products Ltd.
Dow Corning Corp. Quattro Research
e2v technologies Plc. SAFE BioPharma Association
Eli Lilly and Company SAIC
Elsevier Inc. Sanofi-Aventis
eOrganized World Schering Plough
Esteve Scientific Computing World
Europa Science Ltd Siemens
Evotec UK Solvay Pharmaceuticals BV
F Hoffmann La Roche Ltd. STARLIMS
FDA Swedish Prosecution Authority
Ferring Symyx Job function Name Total %
Galderma R&D Syngenta Crop Protection AG
GE Healthcare AS Synthon BV IT, Informatics, Data Management,
Genentech, Inc. Takeda Pharmaceutical Company ELN Project Managers &
General Mills The Edge Software Consultancy System Architects 39.2
Genmab AS Thermo Fisher Scientific
Genzyme Ltd. Thrombogenics NV Scientists 18.1
GeoMetrick Enterprises Thomson Reuters
GGA Software Services Total Petrochemicals Research Feluy
Business Analysts 11.2
GlaxoSmithKline UCB Celltech CIOs/ Senior Directors 9.6
Google UCB Pharma SA
Grunenthal GmbH Unilever Plc. Industry Technology Providers 7.2
Henkel KgaA United States Patent and Trademark Office QA/ QC 7.2
Hoxie & Associates LLC University of Antwerp
IDBS University of Cambridge Patent/ IP/ Regulatory 3.8
Incyte Corporation URGO Laboratories
Infineum UK Ltd. Vernalis
Consultants 2.5
InfoChem GmbH VIB Academics 1.2
Innogenetics NV Waters
CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com

8. 10th Annual 5 WAYS TO REGISTER
Two Day Conference:
27th-28th September 2011 Freephone: 0800 652 2363 or
Pre-Conference Focus Day & Workshops: +44 (0)20 7368 9300
26th September 2011 Fax: +44 (0)20 7368 9301
Venue: Hilton, Barcelona, Spain
Post: your booking form to
IQPC Ltd.
To speed registration, please provide the priority code located on the mailing label or in the box below. 129 Wilton Road,
My registration code is PDFW
London SW1V 1JZ
Please contact our database manager on +44(0) 207 368 9300 or at database@iqpc.co.uk quoting the registration Online: www.elnforum.com
code above to inform us of any changes or to remove your details.
Email: enquire@iqpc.co.uk
Register and
Register and Pay Register and Pay Standard
PACKAGES Pay before
before 27th May* before 1st July* Price
2nd September*
Conference + Focus Day + 2 Workshops €4046+VAT €4096+VAT €4196+VAT €4,646+VAT
Team Discounts*
+ Audio Recordings *** Save €600 Save €550 Save €450
IQPC recognises the value of learning in teams. Groups of 3 or more
Conference + 2 Workshops €3297+VAT €3347+VAT €3447+VAT booking at the same time from the same company receive a 10%
€3,747+VAT
+ Audio Recordings*** Save €450 Save €400 Save €300
discount. 5 or more receive a 15% discount. 7 receive a 20% discount.
Conference + Focus Day + 1 Workshop ** €3497+VAT €3547+VAT €3647+VAT €3,997+VAT Only one discount available per person.
+ Audio Recordings*** Save €500 Save €450 Save €350
Conference + 1 Workshop** €2,748+VAT €2,798+VAT €2,898+VAT €3,098+VAT
+ Audio Recordings***
Conference + Focus Day
Save €350
€2948+VAT
Save €300
€2998+VAT
Save €200
€3089+VAT
Venue & Accommodation
€3,348+VAT VENUE: Avda. Diagonal, 589-591, 08014 Barcelona Spain
+ Audio Recordings*** Save €400 Save €350 Save €250
Conference only €2149+VAT €2249+VAT €2349+VAT Tel: +34 93 495 77777
€2,449+VAT
+ Audio Recordings*** Save €300 Save €200 Save €100 ACCOMMODATION: Travel and accommodation are not included in the
Focus Day Only €899+VAT €899+VAT €899+VAT €899+VAT registration fee, however, a number of discounted bedrooms have been
reserved at the Hilton Barcelona Hotel. Please call the hotel directly on
Workshop only [Each]** €649+VAT €649+VAT €649+VAT €649+VAT Tel: + 34 93 495 7777 and quote booking reference IQPC to receive your
Audio recordings €550+VAT €550+VAT €550+VAT €550+VAT discounted rate, prices start from €160 including taxes and breakfast.
There is limited availability and this is a very busy period in Barcelona so
*All ‘Early Bird’ discounts must require payment at time of registration and before the cut-off date in order to receive any discount. we do encourage attendees to book early to avoid disappointment.
Any discounts offered whether by (including team discounts) must also require payment at the time of registration.
All discount offers cannot be combined with any other offer.
**Please select you choice of workshop A 6 B 6 Free Online Resources
***Please tick if you wish to opt out for Audio Recordings (reducing the price by €550)
All prices are subject to Spanish VAT at 18%. VAT Registration # N 006596 D
To claim a variety of articles, podcasts and other free resources please
visit www.elnforum.com
Delegate Details
Please photocopy for each additional delegate
Digital Conference On CD-ROM
6 Mr 6 Mrs 6 Miss 6 Ms 6 Dr 6 Other A digital version of the conference proceedings, including all
presentations, is available to buy.
First Name Family Name 6 I cannot attend the event, please send me the CD Rom priced at
Job Title £599 plus VAT
Tel No. Recent digital conferences available - £599 plus VAT each
Email
6 Yes I would like to receive information about products and services via email 6 9th Annual ELNs & Advanced Laboratory Solutions, September 2010
Organisation 6 6th Annual Smartlab Exchange, February-March 2011
Nature of business 6 Laboratory Data & Information Management Summit, May 2011
Address
6 Please send me conference materials indicated above.
Postcode Country
6 I have filled out credit card details below
Telephone Fax For further information Please call: 0207 368 9300
Approving Manager or email: knowledgebank@iqpc.co.uk.
Name of person completing form if different from delegate: To search IQPC’s archived conference documentation
visit: www.iqpcknowledgebank.com
Signature
I agree to IQPC’s cancellation, substitution and payment terms
Special dietary requirements: 6 Vegetarian 6 Non-dairy 6 Other (please specify) Terms and Conditions
Please indicate if you have already registered by Phone 6 Fax 6 Email 6 Web 6 Please read the information listed below as each booking is subject to IQPC Ltd standard terms and conditions.
Return of this email will indicate that you accept these terms.
Please note: if you have not received an acknowledgement before the conference, please call us to confirm your booking.
Payment Terms: Upon completion and return of the registration form full payment is required no later than 5
business days from the date of invoice. Payment of invoices by means other than by credit card, or purchase order
(UK Plc and UK government bodies only) will be subject to a €65 (plus VAT) per delegate processing fee. Payment
Payment Method must be received prior to the conference date. We reserve the right to refuse admission to the conference if payment
has not been received.
IQPC Cancellation, Postponement and Substitution Policy: You may substitute delegates at any time by provid-
Total price for your Organisation: (Add total of all individuals attending): ing reasonable advance notice to IQPC.
For any cancellations received in writing not less than eight (8) days prior to the conference, you will receive a 90%
Card Number: VISA 6 M/C 6 AMEX 6 credit to be used at another IQPC conference which must occur within one year from the date of issuance of such
credit. An administration fee of 10% of the contract fee will be retained by IQPC for all permitted cancellations. No
6666666666666666 credit will be issued for any cancellations occurring within seven (7) days (inclusive) of the conference.
In the event that IQPC cancels an event for any reason, you will receive a credit for 100% of the contract fee paid.
Exp. Date: 6 6 6 6 Sec: 6 6 6 6
You may use this credit for another IQPC event to be mutually agreed with IQPC, which must occur within one year
Conference code 11147.005
from the date of cancellation.
In the event that IQPC postpones an event for any reason and the delegate is unable or unwilling to attend in on the
rescheduled date, you will receive a credit for 100% of the contract fee paid. You may use this credit for another
Name On Card: Signature: IQPC event to be mutually agreed with IQPC, which must occur within one year from the date of postponement.
Except as specified above, no credits will be issued for cancellations. There are no refunds given under any
circumstances.
Billing Address (if different from below): IQPC is not responsible for any loss or damage as a result of a substitution, alteration or cancellation/postponement
of an event. IQPC shall assume no liability whatsoever in the event this conference is cancelled, rescheduled or
postponed due to a fortuitous event, Act of God, unforeseen occurrence or any other event that renders performance
City/County/Postcode Cheque enclosed for: € (Made payable to IQPC Ltd.) of this conference impracticable, illegal or impossible. For purposes of this clause, a fortuitous event shall include,
but not be limited to: war, fire, labour strike, extreme weather or other emergency.
Please note that while speakers and topics were confirmed at the time of publishing, circumstances beyond the
By Direct Transfer: (Please quote 11147.005 with remittance advice) IQPC Bank details: HSBC Bank, 67 George control of the organizers may necessitate substitutions, alterations or cancellations of the speakers and/or topics.
As such, IQPC reserves the right to alter or modify the advertised speakers and/or topics if necessary without any
Street, Richmond, Surrey, TW9 1HG Account No: 59090618 Sort Code: 40 05 15 Account No: 59090618 liability to you whatsoever. Any substitutions or alterations will be updated on our web page as soon as possible.
IBAN Code: GB98 MIDL 4005 1559 0906 18 Swift Code: MIDLGB22 Discounts
All ‘Early Bird’ Discounts require payment at time of registration and before the cut-off date in order to receive any
discount. Any discounts offered whether by IQPC (including team discounts) must also require payment at the time of
registration. All discount offers cannot be combined with any other offer
PAYMENT MUST BE RECEIVED PRIOR TO THE CONFERENCE 6 Please do not pass my information to any third party